Aileron Therapeutics Inc. (NASDAQ: ALRN) Stock Information | RedChip
Image

ASK REDCHAT® ANYTHING ABOUT AILERON THERAPEUTICS INC.

Aileron Therapeutics Inc. (NASDAQ: ALRN)
Listen to this Section


$2.12
+0.0100 ( +8.16% ) 63.4K

Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. The company currently has two product candidates in clinical development, LTI-03 and LTI-01, and multiple candidates in preclinical development focused on fibrosis indications.

Market Data


Open $2.12
Previous Close $2.11
Volume 63.4K
Market Cap $45.72M
Day Range $1.90 - $2.16
52 Week Range $1.61 - $7.42
Shares Outstanding 21.67M
Change % +8.16%
Net Change ▲ 0.0100
Insider Ownership -0.07%
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology: Pharmaceutical Preparations
IPO Year 2017
Country United States
Under Writer IPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -37,258.00

Date Type Amount Purchased Purchaser
2024-12-09 Buy 239.00 WINDSOR JAMES BRIAN
2024-06-17 Sale -1900.00 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
2024-06-12 Sale -9577.00 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
2024-06-07 Sale -6291.00 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
2024-05-01 Sale -6680.00 UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
2024-03-06 Sale -2000.00 WINDSOR JAMES BRIAN
2024-03-01 Sale -2725.00 VON RICKENBACH JOSEF H
2024-03-01 Sale -2725.00 Ambros Reinhard J.
2023-12-18 Buy 225.00 WINDSOR JAMES BRIAN
2023-11-21 Buy 5076.00 WINDSOR JAMES BRIAN

Institutional Ownership

Total Market Value $ 0.00

Symbol Issuer Name Market Value ↓ Share Quantity
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Jan 10, 2025
4 Insider transactions 1 Dec 09, 2024
4 Insider transactions 1 Dec 06, 2024
4 Insider transactions 1 Dec 06, 2024
4 Insider transactions 1 Dec 06, 2024
4 Insider transactions 1 Dec 06, 2024
4 Insider transactions 1 Dec 06, 2024
4 Insider transactions 1 Dec 04, 2024
8-k 8K-related 15 Nov 14, 2024
10-q Quarterly Reports 67 Nov 14, 2024

Latest News


× Before browsing our site, please accept our cookies policy